Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kristopher M. Curtis is active.

Publication


Featured researches published by Kristopher M. Curtis.


Proceedings of the National Academy of Sciences of the United States of America | 2003

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

Boyd Yount; Kristopher M. Curtis; Elizabeth A. Fritz; Lisa E. Hensley; Peter B. Jahrling; Erik Prentice; Mark R. Denison; Thomas W. Geisbert; Ralph S. Baric

A previously undescribed coronavirus (CoV) is the etiologic agent responsible for severe acute respiratory syndrome (SARS). Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV) that contained the expected marker mutations inserted into the component clones. Recombinant viruses replicated as efficiently as WT virus and both were inhibited by treatment with the cysteine proteinase inhibitor (2S,3S)-transepoxysuccinyl-l-leucylamido-3-methylbutane ethyl ester. In addition, subgenomic transcripts were initiated from the consensus sequence ACGAAC in both the WT and infectious clone SARS-CoV. Availability of a SARS-CoV full-length cDNA provides a template for manipulation of the viral genome, allowing for the rapid and rational development and testing of candidate vaccines and therapeutics against this important human pathogen.


Journal of Virology | 2000

Strategy for Systematic Assembly of Large RNA and DNA Genomes: Transmissible Gastroenteritis Virus Model

Boyd Yount; Kristopher M. Curtis; Ralph S. Baric

ABSTRACT A systematic method was developed to assemble functional full-length genomes of large RNA and DNA viruses. Coronaviruses contain the largest single-stranded positive-polarity RNA genome in nature. The ∼30-kb genome, coupled with regions of genomic instability, has hindered the development of a full-length infectious cDNA construct. We have assembled a full-length infectious construct of transmissible gastroenteritis virus (TGEV), an important pathogen in swine. Using a novel approach, six adjoining cDNA subclones that span the entire TGEV genome were isolated. Each clone was engineered with unique flanking interconnecting junctions which determine a precise systematic assembly with only the adjacent cDNA subclones, resulting in an intact TGEV cDNA construct of ∼28.5 kb in length. Transcripts derived from the full-length TGEV construct were infectious, and progeny virions were serially passaged in permissive host cells. Viral antigen production and subgenomic mRNA synthesis were evident during infection and throughout passage. Plaque-purified virus derived from the infectious construct replicated efficiently and displayed similar plaque morphology in permissive host cells. Host range phenotypes of the molecularly cloned and wild-type viruses were similar in cells of swine and feline origin. The recombinant viruses were sequenced across the unique interconnecting junctions, conclusively demonstrating the marker mutations and restriction sites that were engineered into the component clones. Full-length infectious constructs of TGEV will permit the precise genetic modification of the coronavirus genome. The method that we have designed to generate an infectious cDNA construct of TGEV could theoretically be used to precisely reconstruct microbial or eukaryotic genomes approaching several million base pairs in length.


Journal of Virology | 2002

Heterologous Gene Expression from Transmissible Gastroenteritis Virus Replicon Particles

Kristopher M. Curtis; Boyd Yount; Ralph S. Baric

ABSTRACT We have recently isolated a transmissible gastroenteritis virus (TGEV) infectious construct designated TGEV 1000 (B. Yount, K. M. Curtis, and R. S. Baric, J. Virol. 74:10600–10611, 2000). Using this construct, a recombinant TGEV was constructed that replaced open reading frame (ORF) 3A with a heterologous gene encoding green fluorescent protein (GFP). Following transfection of baby hamster kidney (BHK) cells, a recombinant TGEV (TGEV-GFP2) was isolated that replicated efficiently and expressed GFP. Replicon constructs were constructed that lacked either the ORF 3B and E genes or the ORF 3B, E, and M genes [TGEV-Rep(AvrII) and TGEV-Rep(EcoNI), respectively]. As the E and M proteins are essential for TGEV virion budding, these replicon RNAs should replicate but not result in the production of infectious virus. Following cotransfection of BHK cells with the replicon RNAs carrying gfp, GFP expression was evident by fluorescent microscopy and leader-containing transcripts carrying gfp were detected by reverse transcription-PCR (RT-PCR). Subsequent passage of cell culture supernatants onto permissive swine testicular (ST) cells did not result in the virus, GFP expression, or the presence of leader-containing subgenomic transcripts, demonstrating the single-hit nature of the TGEV replicon RNAs. To prepare a packaging system to assemble TGEV replicon particles (TGEV VRP), the TGEV E gene was cloned into a Venezuelan equine encephalitis (VEE) replicon expression vector and VEE replicon particles encoding the TGEV E protein were isolated [VEE-TGEV(E)]. BHK cells were either cotransfected with TGEV-Rep(AvrII) (E gene deletion) and VEE-TGEV(E) RNA transcripts or transfected with TGEV-Rep(AvrII) RNA transcripts and subsequently infected with VEE VRPs carrying the TGEV E gene. In both cases, GFP expression and leader-containing GFP transcripts were detected in transfected cells. Cell culture supernatants, collected ∼36 h posttransfection, were passed onto fresh ST cells where GFP expression was evident ∼18 h postinfection. Leader-containing GFP transcripts containing the ORF 3B and E gene deletions were detected by RT-PCR. Recombinant TGEV was not released from these cultures. Under identical conditions, TGEV-GFP2 spread throughout ST cell cultures, expressed GFP, and formed viral plaques. The development of infectious TGEV replicon particles should assist studies of TGEV replication and assembly as well as facilitate the production of novel swine candidate vaccines.


Proceedings of the National Academy of Sciences of the United States of America | 2007

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

Zhongyu Zhu; Samitabh Chakraborti; Yuxian He; Anjeanette Roberts; Timothy Sheahan; Xiaodong Xiao; Lisa E. Hensley; Ponraj Prabakaran; Barry Rockx; Igor A. Sidorov; Davide Corti; Leatrice Vogel; Yang Feng; Jae-Ouk Kim; Lin-Fa Wang; Ralph S. Baric; Antonio Lanzavecchia; Kristopher M. Curtis; Gary J. Nabel; Kanta Subbarao; Shibo Jiang; Dimiter S. Dimitrov

The severe acute respiratory syndrome coronavirus (SARS-CoV) caused a worldwide epidemic in late 2002/early 2003 and a second outbreak in the winter of 2003/2004 by an independent animal-to-human transmission. The GD03 strain, which was isolated from an index patient of the second outbreak, was reported to resist neutralization by the human monoclonal antibodies (hmAbs) 80R and S3.1, which can potently neutralize isolates from the first outbreak. Here we report that two hmAbs, m396 and S230.15, potently neutralized GD03 and representative isolates from the first SARS outbreak (Urbani, Tor2) and from palm civets (SZ3, SZ16). These antibodies also protected mice challenged with the Urbani or recombinant viruses bearing the GD03 and SZ16 spike (S) glycoproteins. Both antibodies competed with the SARS-CoV receptor, ACE2, for binding to the receptor-binding domain (RBD), suggesting a mechanism of neutralization that involves interference with the SARS-CoV–ACE2 interaction. Two putative hot-spot residues in the RBD (Ile-489 and Tyr-491) were identified within the SARS-CoV spike that likely contribute to most of the m396-binding energy. Residues Ile-489 and Tyr-491 are highly conserved within the SARS-CoV spike, indicating a possible mechanism of the m396 cross-reactivity. Sequence analysis and mutagenesis data show that m396 might neutralize all zoonotic and epidemic SARS-CoV isolates with known sequences, except strains derived from bats. These antibodies exhibit cross-reactivity against isolates from the two SARS outbreaks and palm civets and could have potential applications for diagnosis, prophylaxis, and treatment of SARS-CoV infections.


Journal of Virology | 2004

Reverse Genetic Analysis of the Transcription Regulatory Sequence of the Coronavirus Transmissible Gastroenteritis Virus

Kristopher M. Curtis; Boyd Yount; Amy C. Sims; Ralph S. Baric

ABSTRACT Coronavirus discontinuous transcription uses a highly conserved sequence (CS) in the joining of leader and body RNAs. Using a full-length infectious construct of transmissable gastroenteritis virus, the present study demonstrates that subgenomic transcription is heavily influenced by upstream flanking sequences and supports a mechanism of transcription attenuation that is regulated in part by a larger domain composed of primarily upstream flanking sequences which select appropriately positioned CS elements for synthesis of subgenomic RNAs.


Advances in Experimental Medicine and Biology | 2001

A Simple Strategy to Assemble Infectious RNA and DNA Clones

Kristopher M. Curtis; Boyd Yount; Ralph S. Baric

The availability of infectious full-length cDNA clones is important for the molecular genetic analysis of the structure and function of RNA virus genomes (Ahlquist et al, 1984; Boursnell et al., 1987). Infectious cDNA clones for a number of positive-stranded RNA viruses have been developed, advancing our understanding of the molecular mechanisms of viral replication and pathogenesis, and has resulted in novel approaches for heterologous gene expression and vaccine development. Clearly, a full-length infectious construct of TGEV would enhance our understanding of all aspects of TGEV biology by providing a means for reverse genetic analysis.


Advances in Experimental Medicine and Biology | 2001

MHV Subgenomic Negative Strand Function

Ralph S. Baric; Kristopher M. Curtis; Boyd Yount

Mouse hepatitis virus (MHV), a member of Nidovirales, contains a -32 KB linear, single-stranded, positive polarity RNA genome. Upon entry into the cell, the viral genome is transcribed into 7-8 subgenomic mRNAs ranging in size from ∼1.0-32.0 KB. The positive strand mRNAs are arranged in a 3′ co-terminal nested set, and each contains a 5’ end ∼72 nucleotide (nt) leader RNA sequence which is derived from the 5′ end of the genome. Leader RNA sequences are joined to body sequences of each subgenomic length mRNA at highly conserved transcriptional start (TSE) sites located just upstream from the coding sequences of each viral gene (Baric et al., 1983; Sethna et al, 1989). In addition to the viral mRNAs, both full-length as well as subgenomic length negative strand RNAs and replicative form (RF) RNAs have been detected in porcine transmissible gastro-enteritis virus (TGEV), bovine Coronavirus (BCV) and MHV-infected cells (Baric et al., 1983, Sethna et al., 1989; 1991; Sawicki and Sawicki, 1990). The subgenomic length negative strand RNA contains antileader RNA sequences (Sethna et al., 1991). It has been suggested that the subgenomic length negative strands function as dead end products of transcription (Yokomori et al., 1992; Jeong and Makino, 1992). In this manuscript, we provide direct evidence that the subgenomic negative strands function as the principle templates for the synthesis of each corresponding mRNA.


Archive | 2004

Methods and compositions for infectious cDNA of SARS coronavirus

Ralph S. Baric; Boyd Yount; Kristopher M. Curtis


Archive | 2006

Compositions of coronaviruses with a recombination-resistant genome

Ralph S. Baric; Rhonda S. Roberts; Boyd Yount; Kristopher M. Curtis


Archive | 2002

Methods for producing recombinant coronavirus

Kristopher M. Curtis; Boyd Yount; Ralph S. Baric

Collaboration


Dive into the Kristopher M. Curtis's collaboration.

Top Co-Authors

Avatar

Ralph S. Baric

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Boyd Yount

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Amy C. Sims

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Lisa E. Hensley

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Timothy Sheahan

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Alan C. Whitmore

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Ande West

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Anjeanette Roberts

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Barry Rockx

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Damon Deming

University of North Carolina at Chapel Hill

View shared research outputs
Researchain Logo
Decentralizing Knowledge